关注
Pasqualina (Lina) Colella
Pasqualina (Lina) Colella
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
TFEB links autophagy to lysosomal biogenesis
C Settembre, C Di Malta, VA Polito, MG Arencibia, F Vetrini, S Erdin, ...
science 332 (6036), 1429-1433, 2011
31032011
Emerging issues in AAV-mediated in vivo gene therapy
P Colella, G Ronzitti, F Mingozzi
Molecular Therapy-Methods & Clinical Development 8, 87-104, 2018
8432018
Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice
M Allocca, M Doria, M Petrillo, P Colella, M Garcia-Hoyos, D Gibbs, ...
The Journal of clinical investigation 118 (5), 1955-1964, 2008
3582008
Effective delivery of large genes to the retina by dual AAV vectors
I Trapani, P Colella, A Sommella, C Iodice, G Cesi, S de Simone, ...
EMBO molecular medicine 6 (2), 194-211, 2014
2622014
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
F Puzzo, P Colella, MG Biferi, D Bali, NK Paulk, P Vidal, F Collaud, ...
Science translational medicine 9 (418), eaam6375, 2017
1232017
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors
P Colella, I Trapani, G Cesi, A Sommella, A Manfredi, A Puppo, C Iodice, ...
Gene therapy 21 (4), 450-456, 2014
1162014
Ocular gene therapy: current progress and future prospects
P Colella, G Cotugno, A Auricchio
Trends in molecular medicine 15 (1), 23-31, 2009
1012009
Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease
I Trapani, E Toriello, S De Simone, P Colella, C Iodice, EV Polishchuk, ...
Human molecular genetics 24 (23), 6811-6825, 2015
962015
AAV gene transfer with tandem promoter design prevents anti-transgene immunity and provides persistent efficacy in neonate pompe mice
P Colella, P Sellier, HC Verdera, F Puzzo, L van Wittenberghe, ...
Molecular Therapy-Methods & Clinical Development 12, 85-101, 2019
762019
Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients
P Colella, A Auricchio
Human gene therapy 23 (8), 796-807, 2012
642012
Effective delivery of large genes by dual aav vectors
A Auricchio, P Colella, I Trapani
532016
Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration
P Colella, C Iodice, U Di Vicino, I Annunziata, EM Surace, A Auricchio
Human molecular genetics 20 (11), 2251-2262, 2011
462011
Engineering monocyte/macrophage− specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
SG Scharenberg, E Poletto, KL Lucot, P Colella, A Sheikali, TJ Montine, ...
Nature Communications 11 (1), 3327, 2020
422020
Myosin7a deficiency results in reduced retinal activity which is improved by gene therapy
P Colella, A Sommella, E Marrocco, U Di Vicino, E Polishchuk, ...
PloS one 8 (8), e72027, 2013
372013
Rescue of GSDIII phenotype with gene transfer requires liver-and muscle-targeted GDE expression
P Vidal, S Pagliarani, P Colella, HC Verdera, L Jauze, M Gjorgjieva, ...
Molecular Therapy 26 (3), 890-901, 2018
362018
Gene therapy for Pompe disease: the time is now
P Colella, F Mingozzi
Human gene therapy 30 (10), 1245-1262, 2019
352019
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients
E Masat, P Laforêt, M De Antonio, G Corre, B Perniconi, N Taouagh, ...
Scientific reports 6 (1), 36182, 2016
342016
AAV-mediated gene supply for treatment of degenerative and neovascular retinal diseases
P Colella, A Auricchio
Current gene therapy 10 (5), 371-380, 2010
322010
Role of regulatory T cell and effector T cell exhaustion in liver-mediated transgene tolerance in muscle
J Poupiot, HC Verdera, R Hardet, P Colella, F Collaud, L Bartolo, ...
Molecular Therapy-Methods & Clinical Development 15, 83-100, 2019
242019
Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates
H Costa-Verdera, F Collaud, CR Riling, P Sellier, JML Nordin, ...
Nature Communications 12 (1), 6393, 2021
202021
系统目前无法执行此操作,请稍后再试。
文章 1–20